Whitehawk Therapeutics (WHWK) Other Non Operating Income (2016 - 2026)

Whitehawk Therapeutics (WHWK) has reported Other Non Operating Income for 8 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income fell 98.49% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $3.1 million (down 96.41% YoY), while the FY2025 annual figure was $93.8 million, up 2345200.0% from the prior year.
• Other Non Operating Income declined to $1.3 million in Q1 2026 per WHWK's latest filing, from $1.6 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $88.2 million in Q1 2025 and bottomed at -$3.1 million in Q4 2024.
• Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of $1.0 million in 2024.
• Annual changes were most pronounced in 2024 — Other Non Operating Income slumped 150.15% — and 2025, when it soared 8823500.0%.
• Whitehawk Therapeutics' Other Non Operating Income stood at $1.5 million in 2022, then soared by 298.13% to $6.2 million in 2023, then plunged by 150.15% to -$3.1 million in 2024, then soared by 152.86% to $1.6 million in 2025, then slipped by 18.83% to $1.3 million in 2026.
• Business Quant data shows WHWK's Other Non Operating Income at $1.3 million in Q1 2026, $1.6 million in Q4 2025, and $158000.0 in Q2 2025.